05-12 Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 CI
05-12 Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 CI
05-12 Organigram Global Inc. Reports Impairment of Property, Plant and Equipment, Intangible Assets and Goodwill for the Second Quarter Ended March 31, 2026 CI
05-12 Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8) PU
05-12 Organigram Global Inc., Q2 2026 Earnings Call, May 12, 2026
05-12 OrganiGram: Fiscal Q2 Earnings Snapshot AQ
05-12 Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance MT
05-12 Organigram Global : Press Release (dad9ab a96f5298) PU
05-12 Earnings Flash (OGI) Organigram Global Inc. Reports Q2 Net Loss $0.9M Vs Net Income of $42.5M in Q2 Fiscal 2025 MT
05-12 Organigram Q2 Adjusted EBITDA $0.9M, Down 82% YoY MT
05-12 Organigram Q2 Net Revenue $59.8M, Down 9% YoY MT
05-12 Organigram Reports Second Quarter Fiscal 2026 Results BU
05-06 Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026 BU
04-15 Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc. CI
04-15 Organigram Closes the 107.3-Million Acquisition of Germany's Sanity Group MT
04-15 Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities BU
04-15 Organigram Closes Senior Secured Credit Facilities CI
04-15 Organigram Global Inc. Appoints Max Konrad Narr to the Board of Directors CI
04-14 Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc. CI
04-14 Organigram Global Inc. completed the acquisition of remaining 91% stake in The Sanity Group GmbH from BT DE Investments Inc. and others for approximately ?220 million. CI
03-31 Organigram Announced Shareholder Approval of Acquisition of Sanity Group GmbH MT
03-30 Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting BU
03-30 Organigram Global Inc. - Shareholder/Analyst Call
03-23 Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition MT
03-23 Organigram Brief: ISS Citing "Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence" in Recommending Shareholders Vote FOR the Transaction Resolution MT
No results match your criteria
  1. Stock Market
  2. Stocks
  3. OGI Stock
  4. News Organigram Global Inc.